JNJ

WEEKLY MARKET DIGEST: GOVERNMENT SHUTDOWN HAMPERS A GOOD SET UP FOR A RALLY $DIA $GLD $QQQ $SLV $SPY $TBT $USO

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market

Read More

WHAT IF THE DOW FELL ANOTHER 4,000-PLUS POINTS — WOULD YOU BE PREPARED? $AMZN $AAPL $FB $NFLX $GOOG $JNJ $MU $AMD $NVDA $SPY $QQQ $DIA $IWM $GOOGL

Would you be prepared if the Dow Jones Industrial Average fell another 4,000-plus points? That kind of decline sounds shocking. But it’s instructive because it points to an important element of investing: preparedness. The Dow has fallen more than 4,000 points from its high this year — all of it

Read More

THE FED’S POWELL PREVENTED A STOCK MARKET CRASH BY THROWING RED MEAT TO THE BEARS $AAPL $AMZN $NFLX $NVDA $FB $AMD $JNJ $QQQ $SPY $IWM $DJIA

Federal Reserve Chairman Jerome Powell is being universally criticized for what he had to say in the press conference after the release of the central bank’s policy statement. The stock market is giving Powell the thumbs down. But could he be smarter than the rest of the gurus? Let’s explore

Read More

A ‘MUST KNOW’ EVERGREEN STRATEGY TO MAKE MONEY IN THIS VOLATILE STOCK MARKET $TSRO $GSK $RHT $ESL $TDG $AMZN $AAPL $AMZN $FB $NFLX $JNJ $GOOG $MSFT $IBM $SPY

The character of this stock market is changing. What has worked over the past nine years during the bull market may not work in the future. For investors serious about making money, it is high time to brush up on skills and learn new strategies. At The Arora Report we

Read More

UPDATE ON BIOTECH BEAR ETF LABD $LABD $LABU $PPH $PJP $PFE $JNJ $MRK $BMY $BBH $IBB $XBI

This post was just published on ZYX Buy Change Alert. In our divided country there are very few things on which Republicans and Democrats, liberals and conservatives agree.  One of those very few things is that drug prices are too high.  It makes no sense for Americans to often pay ten times

Read More

TRUMP’S ‘OBAMACARE LITE’ PRESENTS OPPORTUNITIES AND PERILS FOR INVESTORS $XBI $MDT $BSX $EW $CYH $THC $PFE $JNJ $MRK $BMY $TEVA $MYL

Republicans have finally produced a detailed plan to repeal and replace the Affordable Care Act, also known as Obamacare. Setting aside politics and viewing the plan neutrally, two things jump out. First, the House Republicans’ plan keeps the basic framework of Obamacare. No wonder some are calling it “Obamacare Lite.”

Read More

CONGRATULATIONS TO THOSE WHO FOLLOWED US ON ACTELION , $70+ ON 121ST BUYOUT, 289.76%+ ANNUALIZED RETURN, BUYER IS JOHNSON & JOHNSON $ALIOY $JNJ

This post was just published on ZYX Buy Change Alert.  Only 62 days ago our call was to buy ALIOY on a potential buyout.  Average price is $45.57.  This is the 121st buyout of our portfolio companies. Over the years, the long-time subscribers to The Arora Report have generated substantial wealth from so many

Read More

BUY ON TRUMP? SELL ON TRUMP? WHO IS RIGHT? $GOOGL $AAPL $FB $INTC $MSFT $NVDA $C $BAC $JPM $MRK

Donald Trump is starting his first full week as U.S. president. Bearish investors have been out in full force, proclaiming, with high confidence, that it’s time to sell stocks. At the same time, bullish gurus are saying just the opposite. So who’s right? Let’s explore the answer. First, we need

Read More

WHAT PHARMA INVESTORS OUGHT TO DO AFTER DONALD TRUMP FIRES A SALVO $LABD $PFE $JNJ $MRK $BMY $LLY $PJP $IHE $PPH $IBB $XHI $BBH $BIS

Donald Trump knocked yet another industry in his press conference Wednesday, but this time it wasn’t manufacturers or car makers. It was health care. And shares of U.S. pharmaceutical companies promptly fell, dropping by an average range of about 3% to 5%. “We’ve got to get our drug industry back,”

Read More

FIVE UNPOPULAR, BUT PRUDENT, THINGS FOR INVESTORS TO DO NEAR DOW 20,000 $MLM $GIS $NVDA $SPY $AAPL $URI $MRK $JNJ $BMY $LLY $AVGO $INTC $ORCL

  I can safely say that, from my 35 years in the financial markets, to be consistently successful at investing, one must put prudence over popularity. Human nature as it is, investors often find it difficult to take unpopular actions. My motivation in writing this column is to nudge you

Read More

A fortune is to be made from AI stocks.
Get the list of 18 AI stocks to grab your share of the profits — no cost to you.

A fortune is to be made from AI stocks.

Get the list of 18 AI stocks to grab your share of the profits.

AI is a $1 Trillion Market

Making A Fortune
In Artificial Intelligence

Golden Age of Artificial Intelligence